Mark Albert, MD
Plastic and Reconstructive Surgery · New York, NYNPI 1598086910
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.1%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Johnson & Johnson at 33.0% of the total. Reporting peaked in 2019 at $3,708 and has fallen 99.6% since, to $16 in 2025.
Across 27 payments — averaging $188.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$1K
- KCI USA, Inc.$1K
- Sientra, Inc.$497
- Musculoskeletal Transplant Foundation Inc.$196
- Mentor Worldwide LLC$166
- plus $278 from 4 others
Across 5 payments — averaging $30,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- KCI USA, Inc.$75K
- Solventum Corporation$75K
What the payments were for
- Consulting fees$2,29045%
- Travel & lodging$501%
- Food & beverage$1,71434%
- Gifts$1,02720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 4 | $1,679 |
| AbbVie | 7 | $1,228 |
| KCI USA, Inc. | 3 | $1,038 |
| Sientra, Inc. | 5 | $497 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $196 |
| Mentor Worldwide LLC | 2 | $166 |
| Acelrx Pharmaceuticals, Inc. | 2 | $124 |
| Integra Lifesciences Corporation | 1 | $116 |
| Coopersurgical, Inc. | 1 | $22 |
| TELA Bio, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STRATAFIX$1,490
- NATRELLE$1,146
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$325
- MENTOR MemoryGel Resterilizable Gel Sizer$144
- PREVENA$140
- BILAYER WOUND MATRIX (BWM)$116
- INTEGRA WOUND MATRIX (IWM)$116
- PRIMATRIX$116
- IDRT$116
- FLOWABLE$116
- DSUVIA$108
- Quickanchor Ethibond$104
- Microfix Quickanchor Ethibond$104
- NA$104
How this compares
$5,081 in reported general payments places this provider in the 75th percentile of 219 plastic and reconstructive surgery providers in New York.
See all plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 13 | $54 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in New York
- Robert GrantNew York$207K
- Christine RohdeNew York$180K
- Steven LevineNew York$108K
- Theodore DiktabanNew York$83K
- Lawrence BassNew York$37K
- Nicholas BastidasNew York$27K
- Philip MillerNew York$24K
- Joseph DisaNew York$21K
- Graham SchwarzNew York$16K
- Evan MatrosNew York$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.